| (S)-colchicine | increases expression | ISO | RGD:731309 | 6480464 | Colchicine results in increased expression of AURKB mRNA | CTD | PMID:21472861 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | increases expression | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of AURKB mRNA | CTD | PMID:20826375 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of AURKB mRNA | CTD | PMID:17555576 PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of AURKB mRNA | CTD | PMID:17942748 PMID:17555576 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:621625 | 6480464 | Ethinyl Estradiol results in decreased expression of AURKB mRNA | CTD | PMID:15834898 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:621625 | 6480464 | Ethinyl Estradiol affects the expression of AURKB mRNA | CTD | PMID:17351261 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AURKB mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | ISO | RGD:731309 | 6480464 | Estradiol results in increased expression of AURKB mRNA | CTD | PMID:16474171 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:731309 | 6480464 | Estradiol results in increased expression of AURKB mRNA | CTD | PMID:16474171 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:731309 | 6480464 | Estradiol results in increased expression of AURKB mRNA | CTD | PMID:20106945 PMID:16474171 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of AURKB mRNA | CTD | PMID:20826375 |
| 17beta-estradiol | increases expression | ISO | RGD:731309 | 6480464 | Estradiol results in increased expression of AURKB mRNA | CTD | PMID:16474171 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AURKB mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731309 | 6480464 | Tetrachlorodibenzodioxin affects the expression of AURKB mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:621625 | 6480464 | Tetrachlorodibenzodioxin affects the expression of AURKB mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to AURKB promoter] | CTD | PMID:19654925 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AURKB mRNA | CTD | PMID:19465110 |
| 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of AURKB mRNA | CTD | PMID:19812364 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of AURKB mRNA | CTD | PMID:20713471 |
| aflatoxin B1 | affects expression | ISO | RGD:731309 | 6480464 | Aflatoxin B1 affects the expression of AURKB protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:731309 | 6480464 | Tretinoin results in decreased expression of AURKB mRNA | CTD | PMID:16249480 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of AURKB mRNA | CTD | PMID:17198874 |
| ammonium chloride | affects expression | ISO | RGD:621625 | 6480464 | Ammonium Chloride affects the expression of AURKB mRNA | CTD | PMID:16483693 |
| arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of AURKB mRNA | CTD | PMID:18929588 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731309 | 6480464 | Benzo(a)pyrene results in decreased expression of AURKB mRNA | CTD | PMID:20106945 |
| bisphenol A | increases expression | ISO | RGD:731309 | 6480464 | bisphenol A results in increased expression of AURKB mRNA | CTD | PMID:16474171 |
| bisphenol A | increases expression | ISO | RGD:731309 | 6480464 | bisphenol A results in increased expression of AURKB mRNA | CTD | PMID:16474171 PMID:22576693 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of AURKB mRNA | CTD | PMID:20826375 |
| calcitriol | decreases expression | ISO | RGD:731309 | 6480464 | Calcitriol results in decreased expression of AURKB mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:731309 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of AURKB mRNA | CTD | PMID:21592394 |
| cefaloridine | decreases expression | ISO | RGD:621625 | 6480464 | Cephaloridine results in decreased expression of AURKB mRNA | CTD | PMID:18500788 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AURKB gene; more ... | CTD | PMID:20938992 |
| cobalt dichloride | decreases expression | ISO | RGD:731309 | 6480464 | cobaltous chloride results in decreased expression of AURKB mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:731309 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of AURKB mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:731309 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of AURKB mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:731309 | 6480464 | Copper Sulfate results in decreased expression of AURKB mRNA | CTD | PMID:19549813 |
| corticosterone | decreases expression | ISO | RGD:621625 | 6480464 | Corticosterone results in decreased expression of AURKB mRNA | CTD | PMID:15755911 |
| coumestrol | multiple interactions | ISO | RGD:731309 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKB mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | ISO | RGD:731309 | 6480464 | Coumestrol results in increased expression of AURKB mRNA | CTD | PMID:19167446 |
| cyclophosphamide | increases expression | ISO | RGD:621625 | 6480464 | Cyclophosphamide results in increased expression of AURKB mRNA | CTD | PMID:11599041 |
| cyclosporin A | decreases expression | ISO | RGD:731309 | 6480464 | Cyclosporine results in decreased expression of AURKB mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:731309 | 6480464 | Cyclosporine results in decreased expression of AURKB mRNA | CTD | PMID:20106945 PMID:21632981 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:731309 | 6480464 | dasatinib results in decreased expression of AURKB mRNA | CTD | PMID:20579391 |
| dibenzofuran | decreases expression | ISO | RGD:621625 | 6480464 | dibenzofuran analog results in decreased expression of AURKB mRNA | CTD | PMID:20566336 |
| dibutyl phthalate | decreases expression | ISO | RGD:621625 | 6480464 | Dibutyl Phthalate results in decreased expression of AURKB mRNA | CTD | PMID:21266533 |
| doxorubicin | affects response to substance | ISO | RGD:731309 | 6480464 | AURKB protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of AURKB; more ... | CTD | PMID:20938992 |
| fulvestrant | multiple interactions | ISO | RGD:731309 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of AURKB mRNA | CTD | PMID:19016759 |
| fulvestrant | decreases expression | ISO | RGD:731309 | 6480464 | fulvestrant results in decreased expression of AURKB mRNA | CTD | PMID:19016759 |
| genistein | increases expression | ISO | RGD:731309 | 6480464 | Genistein results in increased expression of AURKB mRNA | CTD | PMID:16474171 |
| hydrogen peroxide | decreases expression | ISO | RGD:731309 | 6480464 | Hydrogen Peroxide results in decreased expression of AURKB mRNA | CTD | PMID:12414654 |
| hydrogen peroxide | multiple interactions | ISO | RGD:731309 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of AURKB protein | CTD | PMID:18951874 |
| indole-3-methanol | multiple interactions | ISO | RGD:621625 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AURKB mRNA | CTD | PMID:22129741 |
| L-ascorbic acid | multiple interactions | ISO | RGD:731309 | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in increased expression of AURKB mRNA | CTD | PMID:17639512 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AURKB mRNA; more ... | CTD | PMID:20938992 |
| lucanthone | decreases expression | ISO | RGD:731309 | 6480464 | Lucanthone results in decreased expression of AURKB mRNA | CTD | PMID:21148553 |
| LY294002 | decreases expression | ISO | RGD:731309 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of AURKB protein | CTD | PMID:21530604 |
| menadione | decreases expression | ISO | RGD:731309 | 6480464 | Vitamin K 3 results in decreased expression of AURKB mRNA | CTD | PMID:12414654 |
| methyl isocyanate | increases expression | EXP | | 6480464 | methyl isocyanate results in increased expression of AURKB protein | CTD | PMID:22223508 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621625 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AURKB mRNA | CTD | PMID:22129741 |
| naphthalene | increases expression | EXP | | 6480464 | naphthalene results in increased expression of AURKB mRNA | CTD | PMID:18978301 |
| ochratoxin A | increases expression | ISO | RGD:621625 | 6480464 | ochratoxin A results in increased expression of AURKB mRNA | CTD | PMID:19717638 |
| ochratoxin A | increases expression | ISO | RGD:621625 | 6480464 | ochratoxin A results in increased expression of AURKB mRNA | CTD | PMID:19237604 PMID:19717638 |
| ochratoxin A | increases activity | ISO | RGD:621625 | 6480464 | ochratoxin A results in increased activity of AURKB protein | CTD | PMID:19237604 |
| ochratoxin A | increases expression | ISO | RGD:621625 | 6480464 | ochratoxin A results in increased expression of AURKB mRNA | CTD | PMID:19717638 PMID:19237604 |
| pirinixic acid | increases expression | ISO | RGD:621625 | 6480464 | pirinixic acid results in increased expression of AURKB mRNA | CTD | PMID:19162173 PMID:12832660 |
| pirinixic acid | increases expression | ISO | RGD:621625 | 6480464 | pirinixic acid results in increased expression of AURKB mRNA | CTD | PMID:12832660 PMID:19162173 |
| quercetin | multiple interactions | ISO | RGD:731309 | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in increased expression of AURKB mRNA | CTD | PMID:17639512 |
| resveratrol | multiple interactions | ISO | RGD:731309 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of AURKB mRNA | CTD | PMID:19167446 |
| sirolimus | multiple interactions | ISO | RGD:731309 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of AURKB mRNA | CTD | PMID:19016759 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of AURKB mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:731309 | 6480464 | tert-Butylhydroperoxide results in decreased expression of AURKB mRNA | CTD | PMID:12414654 |
| testosterone | decreases expression | ISO | RGD:731309 | 6480464 | Testosterone results in decreased expression of AURKB mRNA | CTD | PMID:21592394 |
| testosterone | multiple interactions | ISO | RGD:731309 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of AURKB mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of AURKB mRNA | CTD | PMID:17484886 |
| theophylline | multiple interactions | ISO | RGD:731309 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of AURKB protein | CTD | PMID:18951874 |
| thioacetamide | increases expression | ISO | RGD:621625 | 6480464 | Thioacetamide results in increased expression of AURKB mRNA | CTD | PMID:22659510 |
| trans-resveratrol | multiple interactions | ISO | RGD:731309 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of AURKB mRNA | CTD | PMID:19167446 |
| trichostatin A | decreases expression | ISO | RGD:731309 | 6480464 | trichostatin A results in decreased expression of AURKB mRNA | CTD | PMID:19606018 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of AURKB mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | ISO | RGD:731309 | 6480464 | troglitazone results in decreased expression of AURKB mRNA | CTD | PMID:19140230 |
| vincaleukoblastine | affects response to substance | ISO | RGD:731309 | 6480464 | AURKB protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 |
| zinc atom | increases expression | ISO | RGD:731309 | 6480464 | Zinc deficiency results in increased expression of AURKB mRNA | CTD | PMID:22171008 |
| zinc(0) | increases expression | ISO | RGD:731309 | 6480464 | Zinc deficiency results in increased expression of AURKB mRNA | CTD | PMID:22171008 |